145 related articles for article (PubMed ID: 37466584)
1. Surgical Duration Is Independently Associated with an Increased Risk of Surgical Site Infection and May Not Be Mitigated by Prolonged Antibiotics: A Secondary Analysis of the PARITY Trial of Infection After Lower-Extremity Endoprosthetic Reconstruction for Bone Tumors.
Zeitlinger L; Wilson M; Randall RL; Thorpe S;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):79-86. PubMed ID: 37466584
[TBL] [Abstract][Full Text] [Related]
2. Patient and Surgical Risk Factors for Surgical Site Infection in Lower-Extremity Oncological Endoprosthetic Reconstruction: A Secondary Analysis of the PARITY Trial Data.
Slawaska-Eng D; Gazendam AM; Kendal J; Schneider P; Becker RG; Freitas JP; Bernthal N; Ghert M;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):41-48. PubMed ID: 37466579
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Antibiotic Regimens In Tumor Surgery (PARITY): a multi-center randomized controlled study comparing alternative antibiotic regimens in patients undergoing tumor resections with endoprosthetic replacements-a statistical analysis plan.
Schneider P; Heels-Ansdell D; Thabane L; Ghert M;
Trials; 2021 Mar; 22(1):223. PubMed ID: 33752752
[TBL] [Abstract][Full Text] [Related]
4. Surgical Site Infection in Patients Managed with an Endoprosthesis for the Treatment of Cancer: Evaluation of Patient, Disease, and Index Surgical Factors.
Ray GS; Werth P; Alexander JH; Eward WC; Bernthal NM; Jeys LM; Funovics P; Windhager R; Temple HT; Lozano-Calderon S; Avedian RS; Jutte PC; Ghert M; Ruggieri P; Henderson ER;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):87-96. PubMed ID: 37466585
[TBL] [Abstract][Full Text] [Related]
5. Surgical Site Infection Is Not Associated with 1-Year Progression-Free Survival After Endoprosthetic Reconstruction for Lower-Extremity Osteosarcoma: A Secondary Analysis of PARITY Study Data.
Jackson KJ; Sullivan CD; Zimel MN; Wustrack RL;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):49-56. PubMed ID: 37466580
[TBL] [Abstract][Full Text] [Related]
6. Operative Treatment and Outcomes of Pediatric Patients with an Extremity Bone Tumor: A Secondary Analysis of the PARITY Trial Data.
Bozzo A; Yeung CM; Van De Sande M; Ghert M; Healey JH;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):65-72. PubMed ID: 37466582
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial.
; Ghert M; Schneider P; Guyatt G; Thabane L; Vélez R; O'Shea T; Randall RL; Turcotte R; Wilson D; Wunder JS; Baptista AM; Cheng EY; Doung YC; Ferguson PC; Giglio V; Hayden J; Heels-Ansdell D; Khan SA; Sampath Kumar V; McKay P; Miller B; van de Sande M; Zumárraga JP; Bhandari M
JAMA Oncol; 2022 Mar; 8(3):345-353. PubMed ID: 34989778
[TBL] [Abstract][Full Text] [Related]
8. Does the Use of Negative Pressure Wound Therapy and Postoperative Drains Impact the Development of Surgical Site Infections?: A PARITY Trial Secondary Analysis.
LiBrizzi CL; Sabharwal S; Forsberg JA; Leddy L; Doung YC; Morris CD; Levin AS;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):34-40. PubMed ID: 37466578
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery.
Gallagher M; Jones DJ; Bell-Syer SV
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005360. PubMed ID: 31557310
[TBL] [Abstract][Full Text] [Related]
10. High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: a systematic review.
Racano A; Pazionis T; Farrokhyar F; Deheshi B; Ghert M
Clin Orthop Relat Res; 2013 Jun; 471(6):2017-27. PubMed ID: 23404421
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related complications in surgical patients.
Gurusamy KS; Koti R; Wilson P; Davidson BR
Cochrane Database Syst Rev; 2013 Aug; (8):CD010268. PubMed ID: 23959704
[TBL] [Abstract][Full Text] [Related]
12. Impact of Postoperative Antibiotic Prophylaxis Duration on Surgical Site Infections in Autologous Breast Reconstruction.
Drury KE; Lanier ST; Khavanin N; Hume KM; Gutowski KA; Thornton BP; Hansen NM; Murphy RX; Fine NA; Kim JY
Ann Plast Surg; 2016 Feb; 76(2):174-9. PubMed ID: 26101972
[TBL] [Abstract][Full Text] [Related]
13. Effect of Extended Prophylactic Antibiotic Duration in the Treatment of Open Fracture Wounds Differs by Level of Contamination.
Stennett CA; O'Hara NN; Sprague S; Petrisor B; Jeray KJ; Leekha S; Yimgang DP; Joshi M; O'Toole RV; Bhandari M; Slobogean GP;
J Orthop Trauma; 2020 Mar; 34(3):113-120. PubMed ID: 32084088
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for All-Cause Early Reoperation Following Tumor Resection and Endoprosthetic Reconstruction: A Secondary Analysis from the PARITY Trial.
Kendal JK; Slawaska-Eng D; Gazendam A; Schneider P; Wessel LE; Ghert M; Bernthal NM;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):4-9. PubMed ID: 37466573
[TBL] [Abstract][Full Text] [Related]
15. Impact of duration of antibiotic prophylaxis on rates of surgical site infection (SSI) in patients undergoing mastectomy without immediate reconstruction, comparing a single prophylactic dose versus continued antibiotic prophylaxis postoperatively: a multicentre, double-blinded randomised control trial protocol.
Sattar AK; Zahid N; Shahzad H; Soomro R; Saleem O; Mahmood SF
BMJ Open; 2021 Jul; 11(7):e049572. PubMed ID: 34244280
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic prophylaxis and incisional surgical site infection following colorectal cancer surgery: an analysis of 330 cases.
Lohsiriwat V; Lohsiriwat D
J Med Assoc Thai; 2009 Jan; 92(1):12-6. PubMed ID: 19260237
[TBL] [Abstract][Full Text] [Related]
17. Central Adjudication Committee and Clinical Site Investigator Agreement on Outcomes in the PARITY Trial: A Secondary Analysis of the PARITY Trial Data.
Slawaska-Eng D; Giglio V; Gazendam AM; Schneider P; Bernthal N; Ghert M;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):73-78. PubMed ID: 37466583
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic Prophylaxis and Resistance in Surgical Site Infection After Immediate Tissue Expander Reconstruction of the Breast.
McCullough MC; Chu CK; Duggal CS; Losken A; Carlson GW
Ann Plast Surg; 2016 Nov; 77(5):501-505. PubMed ID: 25003455
[TBL] [Abstract][Full Text] [Related]
19. Is the Addition of Anaerobic Coverage to Perioperative Antibiotic Prophylaxis During Soft Tissue Sarcoma Resection Associated With a Reduction in the Proportion of Wound Complications?
Ramsey DC; Walker JR; Wetzel R; Gundle KR; Hayden JB; Doung YC
Clin Orthop Relat Res; 2022 Dec; 480(12):2409-2417. PubMed ID: 35901448
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic choice is independently associated with risk of surgical site infection after colectomy: a population-based cohort study.
Hendren S; Fritze D; Banerjee M; Kubus J; Cleary RK; Englesbe MJ; Campbell DA
Ann Surg; 2013 Mar; 257(3):469-75. PubMed ID: 23059498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
